← TrialMatch
HomeTrials

New Assessment System in Measuring Symptom Distress in Cancer Patients

This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to canc

Condition(s)Caregiver, Health Care Provider, Malignant Neoplasm, Physician
StatusRecruiting
Study typeObservational
SummaryThis trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
Who can participateInclusion Criteria: * NORMAL SAMPLES: Community dwelling adults 18 years of age or older * PATIENT SAMPLES: Inpatients and outpatients 18 years of age or older, being followed at UT MD Anderson * EXPERT PANEL PROFESSIONAL PARTICIPANTS: Physician or other healthcare provider with at least 5 years of experience caring for patients with the disease and/or treatment of interest, at least one publication in the last 5 years dealing with the disease and/or treatment of interest (physician only), ability to speak and read English, consent to participate * EXPERT PANEL FAMILY CAREGIVERS PARTICIPANTS: Identification as a family caregiver by patient enrolled as expert panel participant with the disease and/or treatment of interest, 18 years of age or older, ability to speak and read English, consent
Ages18 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorM.D. Anderson Cancer Center
LocationsHouston, Texas, United States
Start date1999-04-13
NCT IDNCT00505245
Official listinghttps://clinicaltrials.gov/study/NCT00505245

🔍 Search all trials →